As of 2025-09-13, the Fair Value of Inhibrx Inc (INBX) is -207.70 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 27.52 USD, the upside of Inhibrx Inc is -854.72%.
With the market price of 27.52 USD and our fair value calculation, Inhibrx Inc (INBX) is not a good investment. Investing in INBX stocks now will result in a potential loss of 854.72%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -76.12 | -81.77 | -145.23 | -241.36 | 1,687.57 | 228.62 |
| YoY growth | -48.09% | -7.42% | -77.61% | -66.19% | 799.19% | 119.97% |
| Market Cap (mil) | 398.76 |
| P/E | |
| Forward P/E | 0.31x |
| EPS | -8.31 |
| Avg earnings growth rate | 119.97% |
| TTM earnings | -120.38 |